Skip to content

Evaluation of Different Continuous Positive Airway Pressure (CPAP) Systems in Patients With Acute Respiratory Failure

The CPAP in Patients Affected by Acute Respiratory Failure

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00876473
Enrollment
30
Registered
2009-04-06
Start date
2009-04-30
Completion date
2014-01-31
Last updated
2015-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Failure

Keywords

CPAP, Acute Respiratory Failure

Brief summary

The aim of this study is to evaluate the performance, the tolerability and the efficacy on gas-exchange of different CPAP (Continuous Positive Airway Pressure) systems.

Detailed description

Three CPAP systems are studied for each patient at the same level of PEEP: 1) continuous high-flow CPAP with fixed value PEEP valve; 2) continuous high-flow CPAP with Boussignac PEEP valve; 3) demand flow CPAP, supplied by a ventilator.

Interventions

PROCEDURECPAP system

Evaluating the effects of different CPAP systems on respiratory mechanics, respiratory effort and gas-exchange CPAP systems: Continuous high-flow CPAP with fixed value PEEP valve Continuous high-flow CPAP with Boussignac valve Demand flow CPAP supplied by ventilator

Sponsors

Policlinico Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Intubated-tracheostomized subjects receiving CPAP during the weaning from invasive mechanical ventilation

Exclusion criteria

* Hemodynamic instability * Barotrauma * Severe myopathy

Design outcomes

Primary

MeasureTime frame
Respiratory mechanics, work of breathing, end-expiratory lung volume (EELV) and gas exchange30 minutes

Secondary

MeasureTime frame
Comfort of breathing30 minutes

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026